Scientific Program | Techical Program | Neurosurgery Conference | Neurology Conference | Neurologists Conference | Spinal Sugery Conference | Paris | Europe | USA | Middle East

<!DOCTYPE html> <html lang="en"> <head> <meta charset="utf-8"> <meta name="viewport" content="width=device-width, initial-scale=1.0"> <meta http-equiv="X-UA-Compatible" content="IE=edge"> <title>Scientific Program | Techical Program | Neurosurgery Conference | Neurology Conference | Neurologists Conference | Spinal Sugery Conference | Paris | Europe | USA | Middle East | 2017</title> <meta name="keywords" content="neurosurgery,neurologists,spine,spinal surgery,neurosurgery conference,neurologists conference,surgery conference,neurosurgery research,neurosurgery journal,neurosurgery article,neurosurgery meaning, neurosurgery congress,neurosurgery 2017,neurosurgeons,n" /> <meta name="description" content="Neurosurgery is a Surgical specialty Conference concerned with various Neurological disorders and injury of Brain, Spine and Nervous system, More at Neurosurgery 2017 Conference on June 19-21, 2017"> <meta property="og:url" content="https://neurosurgery.insightconferences.com/2017/" /> <meta property="og:type" content="website" /> <meta property="og:title" content="Neurosurgery | Neurosurgery Conference | Neurologists Conference | Neurology Conference | Spinal Sugery Conference | Spine Conference | CME Conference | Paris | France | Europe | USA | Middle East | 2017" /> <link rel="canonical" href="https://neurosurgery.insightconferences.com/2017/scientific-program.php?day=3&sid=3426&date=2017-06-21"> <link rel="stylesheet" href="https://maxcdn.bootstrapcdn.com/bootstrap/3.3.4/css/bootstrap.min.css"> <link href="https://d2cax41o7ahm5l.cloudfront.net/cs/css/bootstrap-submenu.min.css" rel="stylesheet"> <link href="//maxcdn.bootstrapcdn.com/font-awesome/4.2.0/css/font-awesome.min.css" rel="stylesheet"> <link href='https://fonts.googleapis.com/css?family=Courgette' rel='stylesheet' type='text/css'> <link rel="stylesheet" href="https://maxcdn.bootstrapcdn.com/bootstrap/3.3.4/css/bootstrap-theme.min.css">    <link href="https://d2cax41o7ahm5l.cloudfront.net/cs/css/style-2016.css" rel="stylesheet">     <link rel="shortcut icon" href="https://d2cax41o7ahm5l.cloudfront.net/cs/images/favicon.png"> <link rel="apple-touch-icon-precomposed" sizes="144x144" href="https://d2cax41o7ahm5l.cloudfront.net/cs/images/apple-touch-icon-144-precomposed.png"> <link rel="apple-touch-icon-precomposed" sizes="114x114" href="https://d2cax41o7ahm5l.cloudfront.net/cs/images/apple-touch-icon-114-precomposed.png"> <link rel="apple-touch-icon-precomposed" sizes="72x72" href="https://d2cax41o7ahm5l.cloudfront.net/cs/images/apple-touch-icon-72-precomposed.png"> <link rel="apple-touch-icon-precomposed" sizes="57x57" href="https://d2cax41o7ahm5l.cloudfront.net/cs/images/apple-touch-icon-57-precomposed.png">  <script type="text/javascript"> _atrk_opts = { atrk_acct:"AQs4j1a4ZP00a6", domain:"insightconferences.com",dynamic: true}; (function() { var as = document.createElement('script'); as.type = 'text/javascript'; as.async = true; as.src = "https://d31qbv1cthcecs.cloudfront.net/atrk.js"; var s = document.getElementsByTagName('script')[0];s.parentNode.insertBefore(as, s); })(); </script> <noscript><img src="https://d5nxst8fruw4z.cloudfront.net/atrk.gif?account=AQs4j1a4ZP00a6" style="display:none" height="1" width="1" alt="" /></noscript>    <script async src="https://www.googletagmanager.com/gtag/js?id=G-E3XEJ9ELN0"></script> <script async src="https://www.googletagmanager.com/gtag/js?id=UA-82632414-17"></script> <script> window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments); } gtag('js', new Date()); gtag('config', 'G-E3XEJ9ELN0'); gtag('config', 'UA-82632414-17'); </script>  <style> #cke_pastebin { position:absolute !important; background: #fff !important; width: auto !important; left: 0 !important; overflow:visible !important; height:auto !important; top: 0 !important; } </style> </head> <body data-id="1991"> <div id="CssFailCheck" class="hidden" style="height:1px;"></div> <header class="clearfix"> <div class="col-md-12 page-header clearfix" > <div class="row"> <div class="col-lg-2 col-md-2 col-sm-4 logo-main"> <h2 class="logo "><a href="https://neurosurgery.insightconferences.com/2017/" title="Home" class="OMICS_Logo"> <img src="https://d2cax41o7ahm5l.cloudfront.net/cs/images/OMICS_logo.png" class="img-responsive" alt="OMICS International"></a> </h2> </p> </div> <div class="col-lg-4 col-md-4 col-sm-8 title-main">  <h1 class="title"><small>13<sup>th</sup> International Conference on </small> <span> Neurology and Neurosurgery</span> <small>June 19-21, 2017 Paris, France</small> </h1> <div class="quick-links visible-xs"> <a href="https://neurosurgery.insightconferences.com/2017/organizing-committee.php" class="btn btn-primary btn-sm"><strong>Organizing Committee</strong></a> <a href="https://neurosurgery.insightconferences.com/2017/abstract-submission.php" class="btn btn-danger btn-sm"><strong>Submit Abstract</strong></a> <a href="https://neurosurgery.insightconferences.com/2017/registration.php" class="btn btn-success btn-sm"><strong>Register Now</strong></a> <a href="https://neurosurgery.insightconferences.com/2017/scientific-program.php" class="btn btn-success btn-sm wrap-link" ><i class="fa fa-download fa-lg"></i> <strong>Scientific Program</strong></a> </div> </div>  <div class="col-lg-6 col-md-6 col-sm-12" style="margin-bottom: 30px;"> <div> <h6 class="text-center text-primary">Recommended Global <span class="text-uppercase text-danger">Neuroscience</span> Conferences</h6> <div class="col-lg-4 col-md-4 col-sm-4 conf-list-region paddingzero"> <div class="conf-list-region-box "> <div class="conf-list"> <h6 class="text-left text-danger">USA & Americas</h6> <div> <ul class="list-unstyled"> <li><a href="https://neurologists.annualcongress.com/" target="_blank" title="Neuro Experts 2025, Canada">Neuro Experts 2025, Canada</a></li> <li><a href="https://braindisorders.neuroconferences.com/" target="_blank" title="Brain Disorders-2025, USA">Brain Disorders-2025, USA</a></li> <li><a href="https://strokesummit.neurologyconference.com/" target="_blank" title="Stroke Summit 2025, Canada">Stroke Summit 2025, Canada</a></li> <li><a href="https://neurogenetics.neuroconferences.com/" target="_blank" title="Neurogenetics 2025, Canada">Neurogenetics 2025, Canada</a></li> <li><a href="" title="" target="_blank"></a></li> </ul> </div> </div> </div> </div> <div class="col-lg-4 col-md-4 col-sm-4 conf-list-region paddingzero"> <div class="conf-list-region-box europe-list"> <div class="conf-list"> <h6 class="text-left text-danger">Europe & Middle East</h6> <div> <ul class="list-unstyled"> <li><a href="https://neurologists.conferenceseries.com/" target="_blank" title="Neurologists Meeting 2025, Netherlands">Neurologists Meeting 2025, Netherlands</a></li> <li><a href="https://spine-disorders.neurologyconference.com/" target="_blank" title="SPINE CONGRESS 2025, UK">SPINE CONGRESS 2025, UK</a></li> <li><a href="https://epilepsycongress.neuroconferences.com/" target="_blank" title="EPILEPSY CONGRESS 2025, France">EPILEPSY CONGRESS 2025, France</a></li> <li><a href="https://neuropaediatrics.annualcongress.com/" target="_blank" title="NEURO PEDIATRICS 2025, UAE">NEURO PEDIATRICS 2025, UAE</a></li> <li><a href="" title="" target="_blank"></a></li> </ul> </div> </div> </div> </div> <div class="col-lg-4 col-md-4 col-sm-4 conf-list-region paddingzero"> <div class="conf-list-region-box asia-pacific-list"> <div class="conf-list"> <h6 class="text-left text-danger">Asia Pacific</h6> <div> <ul class="list-unstyled"> <li><a href="" title="" target="_blank"></a></li> </ul> </div> </div> </div> </div> </div> </div> <div class='col-md-12'> <div class="row"> <div class="col-lg-6 col-md-6 col-sm-6 conf-list-region" > </div> <div style="height:30px;"></div> <div class="col-md-5 col-xs-12 top-search clearfix"> <form id="top-search-form" method="post" action="https://www.conferenceseries.com/search-results/" class="navbar-form" role="search"> <div class="input-group"> <input type="search" class="form-control" placeholder="Search" name="keyword" id="keyword" required> <div class="input-group-btn"> <button type="submit" class="btn btn-info hidden-xs">Search 1000+ Events</button> <button type="submit" class="btn btn-info visible-xs"><span class="glyphicon glyphicon-search" aria-hidden="true"></span></button> </div> </div> </form> </div> </div> </div> </div> </div> </header> <div class="row clearfix"> <nav class="navbar navbar-default kesava" role="navigation"> <div class="navbar-header visible-xs"> <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#main-nav"> <span class="sr-only">Toggle navigation</span> <span class="icon-bar"></span> <span class="icon-bar"></span> <span class="icon-bar"></span> </button> </div> <div class="collapse navbar-collapse" id="main-nav"> <ul class="nav navbar-nav"> <li><a href="https://neurosurgery.insightconferences.com/2017/" title="Home"><span class="glyphicon glyphicon-home" aria-hidden="true"></span> Home</a></li> <li><a href="https://www.omicsonline.org/about.php" title="About Us" target="_blank">About Us</a></li> <li class="dropdown"> <a href="#" title="Explore Our Journals" class="dropdown-toggle" data-toggle="dropdown">Journals<strong class="caret"></strong></a> <ul class="dropdown-menu"> <li><a href="https://www.omicsonline.org/open-access-journals-list.php" title="A-Z Journals" target="_blank">A-Z Journals</a></li> <li><a href="https://www.omicsonline.org/scientific-journals.php" title="Browse by Subject" target="_blank">Browse by Subject</a></li> <li><a href="https://www.omicsonline.org/newly-launched-journals.php" title="Newly Launched Journals" target="_blank">Newly Launched Journals</a></li> <li><a href="https://www.omicsonline.org/open-access.php" title="Open Access" target="_blank">Open Access</a></li> </ul> </li> <li class="dropdown"> <a href="#" title="Explore Our Conferences" class="dropdown-toggle" data-toggle="dropdown">Conferences<strong class="caret"></strong></a> <ul class="dropdown-menu"> <li><a href="https://www.conferenceseries.com/" title="Upcoming Conferences" target="_blank">Upcoming Conferences</a></li> <li><a href="https://www.conferenceseries.com/previous.php" title="Previous Conferences" target="_blank">Previous Conferences</a></li> <li><a href="https://www.conferenceseries.com/past-conference-reports.php" title="Past Conference Reports" target="_blank" >Past Conferences Reports</a></li> </ul> </li>    <li><a href="https://neurosurgery.insightconferences.com/2017/organizing-committee.php" title="Organizing Committee">Organizing Committee</a></li> <li class="dropdown"> <a href="#" title="Conference Details" class="dropdown-toggle" data-toggle="dropdown">Technical Program<strong class="caret"></strong></a> <ul class="dropdown-menu"> <li><a href="https://neurosurgery.insightconferences.com/2017/symposium.php" title="Symposium & Contact Details">Symposium & Contact Details</a></li> <li class="dropdown-submenu"> <a href="#" title="Scientific Program" class="dropdown-toggle" data-toggle="dropdown">Scientific Program</a> <ul class="dropdown-menu"> <li><a href="https://neurosurgery.insightconferences.com/2017/scientific-program.php?day=1&sid=3419&date=2017-06-19" title="Scientific Program Day 1">Day 1: <time datetime="2017-06-19">June 19, 2017</time> </a> </li> <li><a href="https://neurosurgery.insightconferences.com/2017/scientific-program.php?day=2&sid=3425&date=2017-06-20" title="Scientific Program Day 2">Day 2: <time datetime="2017-06-20">June 20, 2017</time> </a> </li> <li><a href="https://neurosurgery.insightconferences.com/2017/scientific-program.php?day=3&sid=3426&date=2017-06-21" title="Scientific Program Day 3">Day 3: <time datetime="2017-06-21">June 21, 2017</time> </a> </li> </ul> </li> <li><a href="https://neurosurgery.insightconferences.com/2017/speaker-guidelines.php" title="Speaker Guidelines & FAQ">Speaker Guidelines & FAQ</a></li> <li><a href="https://neurosurgery.insightconferences.com/2017/young-researchers-forum.php" title="Young Researchers Forum">Young Researchers Forum</a></li> <li><a href="https://neurosurgery.insightconferences.com/2017/cancellation-policy.php" title="Terms and Conditions">Terms & Conditions</a></li> <li><a href="https://network.conferenceseries.com/index.php?id=331" title="B2B" target="_blank">B2B</a></li> </ul> </li> <li><a href="https://neurosurgery.insightconferences.com/2017/venue-hospitality.php" title="Venue and Hospitality">Venue & Hospitality</a></li> <li class="dropdown"> <a href="#" title="Sponsors & Exhibitors Details" class="dropdown-toggle" data-toggle="dropdown">Sponsors / Exhibitors<strong class="caret"></strong></a> <ul class="dropdown-menu"> <li><a href="https://neurosurgery.insightconferences.com/2017/sponsors.php" title="Sponsors">Sponsors</a></li> <li><a href="https://neurosurgery.insightconferences.com/2017/exhibition.php" title="Exhibition">Exhibition</a></li> <li class="dropdown-submenu"> <a href="#" title="Supporters" class="dropdown-toggle" data-toggle="dropdown">Our Supporters</a> <ul class="dropdown-menu"> <li><a href="https://www.omicsonline.org/sponsors-2014.php" title="2014 Supporters" target="_blank">2014 Supporters</a></li> <li><a href="https://www.omicsonline.org/sponsors-2013.php" title="2013 Supporters" target="_blank">2013 Supporters</a></li> <li><a href="https://www.omicsonline.org/sponsors-2012.php" title="2012 Supporters" target="_blank">2012 Supporters</a></li> <li><a href="https://www.omicsonline.org/sponsors-2011.php" title="2011 Supporters" target="_blank">2011 Supporters</a></li> </ul> </li> </ul> </li> <li class="dropdown"> <a href="#" title="Awards" class="dropdown-toggle" data-toggle="dropdown">Awards<strong class="caret"></strong></a> <ul class="dropdown-menu"> <li><a href="https://neurosurgery.insightconferences.com/2017/poster-presentation.php" title="Poster Presentation">Poster Presentation</a></li> <li><a href="https://neurosurgery.insightconferences.com/2017/eposter-presentation.php" title="Poster Presentation">ePoster Presentation</a></li> </ul> </li> </ul>   </div> </nav> </div> <div class="container">    <div class="main-content"> <section class="row"> <div class="col-md-12"> <div class="well well-sm clearfix"> <h2 class="heading ">Scientific Program</h2> <div class="well well-sm content-box-dotted clearfix"> <div class="col-md-8 col-sm-6"> <p>Conference Series Ltd invites all the participants across the globe to attend 13<sup>th</sup> International Conference on Neurology and Neurosurgery Paris, France.</p> </div> <div class="col-md-4 col-sm-6 help-desk"><a class="btn btn-danger" href="https://neurosurgery.insightconferences.com/abstract-submission.php" title="Click for more information">Submit your Abstract</a> <h5>or e-mail to <i class="fa fa-arrow-down"></i></h5> <p> <i class="fa fa-envelope-o"></i> <a href="mailto:events@conferenceseries.com">events@conferenceseries.com</a><br> <i class="fa fa-envelope-o"></i> <a href="mailto:neurosurgery@neuroconferences.org">neurosurgery@neuroconferences.org</a><br> <i class="fa fa-envelope-o"></i> <a href="mailto:neurosurgery2017@protonmail.com">neurosurgery2017@protonmail.com</a><br> </div> </div> <div class="show-special day-schedule text-center clearfix"> <div class="col-md-4 col-sm-4"> <a class="btn btn-success" href="https://neurosurgery.insightconferences.com/2017/scientific-program.php?day=1&sid=3419&date=2017-06-19" title="Click for more information">Scientific Program <span class="badge">Day 1</span></a> </div> <div class="col-md-4 col-sm-4"> <a class="btn btn-success" href="https://neurosurgery.insightconferences.com/2017/scientific-program.php?day=2&sid=3425&date=2017-06-20" title="Click for more information">Scientific Program <span class="badge">Day 2</span></a> </div> <div class="col-md-4 col-sm-4"> <a class="btn btn-success" href="https://neurosurgery.insightconferences.com/2017/scientific-program.php?day=3&sid=3426&date=2017-06-21" title="Click for more information">Scientific Program <span class="badge">Day 3</span></a> </div> </div> <article class="scientific-prog"> <h3 class="heading heading-out">Day 3 : <time datetime="2015-12-07">June 21, 2017</time><span class="heading-shadow"></span></h3> <section class="col-md-12 content-box-dotted"> <div class="affiliation bs-callout"> <h4>Keynote Forum</h4> <h4><a style="color:#63a7f4;" href="https://neurosurgery.insightconferences.com/speaker/2017/walter-bini-healthpoint-hospital-uae" >Walter Bini</a></h4> <p>Healthpoint Hospital, UAE</p> <h6>Keynote: <a style="color:#63a7f4;" href="https://neurosurgery.insightconferences.com/abstract/2017/lumbar-spinal-canal-stenosis-surgical-management-strategies-quo-vadis-where-to" >Lumbar spinal canal stenosis: Surgical management strategies, quo vadis (where to)</a></h6> <p>Time : <b>10:00-10:40</b></p> </div> <div class="speaker-bio-abs"> <div class="bio-main"> <img src="https://d2cax41o7ahm5l.cloudfront.net/cs/speaker-photo/neurosurgery2017-Walter-Bini-5083-63706.jpg" alt="Conference Series Neurosurgery 2017 International Conference Keynote Speaker Walter Bini photo" title="Walter Bini" class="img-responsive thumbnail pull-left"> <div class="bio"> <h5>Biography:</h5> <p><p style="text-align: justify;"> <span style="font-size:12px;">Walter Bini has completed his Diploma at Westminster School, Simsbury Conn. USA and Post-graduate degree at Universidad de Zaragoza, Facultad de Medicina, Zaragoza-Spain. In 2014, he was the Middle East Chairman of ISLASS. He was Head of Neurosurgery at Sheikh Khalifa General Hospital, UAQ-UAE from 2014-2016. Currently, he is Consultant Neurosurgeon in Orthopedic department, spine section of Lanzo Hospital COF, Lanzo d’Intelvi in Italy and also Visiting Consultant Neurosurgeon in Orthopedic department at Healthpoint Hospital, UAE.</span></p> </p> <h5>Abstract:</h5> <p><p style="text-align: justify;"> <span style="font-size:14px;">Lumbar spinal stenosis (LSS) is characterized by a narrowing of the lumbar spinal canal and/or the intervertebral foramina resulting from disc degeneration, bulging of the annulus, facet joint hypertrophy and infolding of the ligamentum flavum. With increase of the aging population and advances in diagnostic imaging capabilities, lumbar spinal stenosis in its different stages or types is becoming more frequently diagnosed with an estimated prevalence of up to 13%. This along with newer technical advances being introduced in the surgical management of LSS continues to pose a topic of discussion among neurologists as well as orthopedic and neurosurgeons as far as treatment strategies are concerned.<br /> Especially the cases of moderate or soft stenosis, very different than the bony or consolidated type, warrant a detailed analysis of the primary interspinous devices used for both types along with a proposal for a decision making protocol. Based on our experience with the management of these two entities, we will focus on our results and future considerations with less invasive procedures which are proving over the last two decades to be a viable alternative for stenosis patients. Core of our presentation are our results with a minimal invasive procedure performed in 121 patients and their corresponding initial follow-up over one year with a 92% success rate evaluated by an independent observer. This is clearly in contrast with the 40-90% success rates and 14-35% complication rates reported and associated with standard decompression surgeries. Furthermore, we will present our considerations of a further novel technique and the direction treatment options are developing towards the corresponding scheduled clinical-trial.</span></p> </p> </div> </div> </div> </section> <section class="col-md-12 content-box-dotted"> <div class="affiliation bs-callout"> <h4>Keynote Forum</h4> <h4><a style="color:#63a7f4;" href="https://neurosurgery.insightconferences.com/speaker/2017/walter-bini-healthpoint-hospital-uae-1146610455" >Walter Bini</a></h4> <p>Healthpoint Hospital, UAE</p> <h6>Keynote: <a style="color:#63a7f4;" href="https://neurosurgery.insightconferences.com/abstract/2017/lumbar-spinal-canal-stenosis-surgical-management-strategies-quo-vadis-where-to" >Lumbar spinal canal stenosis: Surgical management strategies, quo vadis (where to)</a></h6> <p>Time : <b>10:00-10:40</b></p> </div> <div class="speaker-bio-abs"> <div class="bio-main"> <img src="https://d2cax41o7ahm5l.cloudfront.net/cs/speaker-photo/neurosurgery2017-Walter-Bini-5084-76198.jpg" alt="Conference Series Neurosurgery 2017 International Conference Keynote Speaker Walter Bini photo" title="Walter Bini" class="img-responsive thumbnail pull-left"> <div class="bio"> <h5>Biography:</h5> <p><p style="text-align: justify;"> <span style="font-size:12px;">Walter Bini has completed his Diploma at Westminster School, Simsbury Conn. USA and Post-graduate degree at Universidad de Zaragoza, Facultad de Medicina, Zaragoza-Spain. In 2014, he was the Middle East Chairman of ISLASS. He was Head of Neurosurgery at Sheikh Khalifa General Hospital, UAQ-UAE from 2014-2016. Currently, he is Consultant Neurosurgeon in Orthopedic department, spine section of Lanzo Hospital COF, Lanzo d’Intelvi in Italy and also Visiting Consultant Neurosurgeon in Orthopedic department at Healthpoint Hospital, UAE.</span></p> </p> <h5>Abstract:</h5> <p><p style="text-align: justify;"> <span style="font-size:14px;">Lumbar spinal stenosis (LSS) is characterized by a narrowing of the lumbar spinal canal and/or the intervertebral foramina resulting from disc degeneration, bulging of the annulus, facet joint hypertrophy and infolding of the ligamentum flavum. With increase of the aging population and advances in diagnostic imaging capabilities, lumbar spinal stenosis in its different stages or types is becoming more frequently diagnosed with an estimated prevalence of up to 13%. This along with newer technical advances being introduced in the surgical management of LSS continues to pose a topic of discussion among neurologists as well as orthopedic and neurosurgeons as far as treatment strategies are concerned.<br /> Especially the cases of moderate or soft stenosis, very different than the bony or consolidated type, warrant a detailed analysis of the primary interspinous devices used for both types along with a proposal for a decision making protocol. Based on our experience with the management of these two entities, we will focus on our results and future considerations with less invasive procedures which are proving over the last two decades to be a viable alternative for stenosis patients. Core of our presentation are our results with a minimal invasive procedure performed in 121 patients and their corresponding initial follow-up over one year with a 92% success rate evaluated by an independent observer. This is clearly in contrast with the 40-90% success rates and 14-35% complication rates reported and associated with standard decompression surgeries. Furthermore, we will present our considerations of a further novel technique and the direction treatment options are developing towards the corresponding scheduled clinical-trial.</span></p> </p> </div> </div> </div> </section> <section class="col-md-12 content-box-dotted"> <div class="affiliation bs-callout"> <h4>Keynote Forum</h4> <h4><a style="color:#63a7f4;" href="https://neurosurgery.insightconferences.com/speaker/2017/walter-bini-healthpoint-hospital-uae-577954178" >Walter Bini</a></h4> <p>Healthpoint Hospital, UAE</p> <h6>Keynote: <a style="color:#63a7f4;" href="https://neurosurgery.insightconferences.com/abstract/2017/lumbar-spinal-canal-stenosis-surgical-management-strategies-quo-vadis-where-to" >Lumbar spinal canal stenosis: Surgical management strategies, quo vadis (where to)</a></h6> <p>Time : <b>10:00-10:40</b></p> </div> <div class="speaker-bio-abs"> <div class="bio-main"> <img src="https://d2cax41o7ahm5l.cloudfront.net/cs/speaker-photo/neurosurgery2017-Walter-Bini-5085-63133.jpg" alt="Conference Series Neurosurgery 2017 International Conference Keynote Speaker Walter Bini photo" title="Walter Bini" class="img-responsive thumbnail pull-left"> <div class="bio"> <h5>Biography:</h5> <p><p style="text-align: justify;"> <span style="font-size:12px;">Walter Bini has completed his Diploma at Westminster School, Simsbury Conn. USA and Post-graduate degree at Universidad de Zaragoza, Facultad de Medicina, Zaragoza-Spain. In 2014, he was the Middle East Chairman of ISLASS. He was Head of Neurosurgery at Sheikh Khalifa General Hospital, UAQ-UAE from 2014-2016. Currently, he is Consultant Neurosurgeon in Orthopedic department, spine section of Lanzo Hospital COF, Lanzo d’Intelvi in Italy and also Visiting Consultant Neurosurgeon in Orthopedic department at Healthpoint Hospital, UAE.</span></p> </p> <h5>Abstract:</h5> <p><p style="text-align: justify;"> <span style="font-size:14px;">Lumbar spinal stenosis (LSS) is characterized by a narrowing of the lumbar spinal canal and/or the intervertebral foramina resulting from disc degeneration, bulging of the annulus, facet joint hypertrophy and infolding of the ligamentum flavum. With increase of the aging population and advances in diagnostic imaging capabilities, lumbar spinal stenosis in its different stages or types is becoming more frequently diagnosed with an estimated prevalence of up to 13%. This along with newer technical advances being introduced in the surgical management of LSS continues to pose a topic of discussion among neurologists as well as orthopedic and neurosurgeons as far as treatment strategies are concerned.<br /> Especially the cases of moderate or soft stenosis, very different than the bony or consolidated type, warrant a detailed analysis of the primary interspinous devices used for both types along with a proposal for a decision making protocol. Based on our experience with the management of these two entities, we will focus on our results and future considerations with less invasive procedures which are proving over the last two decades to be a viable alternative for stenosis patients. Core of our presentation are our results with a minimal invasive procedure performed in 121 patients and their corresponding initial follow-up over one year with a 92% success rate evaluated by an independent observer. This is clearly in contrast with the 40-90% success rates and 14-35% complication rates reported and associated with standard decompression surgeries. Furthermore, we will present our considerations of a further novel technique and the direction treatment options are developing towards the corresponding scheduled clinical-trial.</span></p> </p> </div> </div> </div> </section> <section class="col-md-12 content-box-dotted"> <div class="affiliation bs-callout"> <h4>Keynote Forum</h4> <h4><a style="color:#63a7f4;" href="https://neurosurgery.insightconferences.com/speaker/2017/hugues-duffau-gui-de-chauliac-hospital-france" >Hugues Duffau</a></h4> <p>Gui de Chauliac Hospital, France</p> <h6>Keynote: <a style="color:#63a7f4;" href="https://neurosurgery.insightconferences.com/abstract/2017/surgery-of-insular-and-paralimbic-diffuse-low-grade-gliomas-technical-considerations" >Surgery of insular and paralimbic diffuse low-grade gliomas: Technical considerations</a></h6> <p>Time : <b>10:40-11:20</b></p> </div> <div class="speaker-bio-abs"> <div class="bio-main"> <img src="https://d2cax41o7ahm5l.cloudfront.net/cs/speaker-photo/neurosurgery2017-Hugues-Duffau-5086-28334.jpg" alt="Conference Series Neurosurgery 2017 International Conference Keynote Speaker Hugues Duffau photo" title="Hugues Duffau" class="img-responsive thumbnail pull-left"> <div class="bio"> <h5>Biography:</h5> <p><p style="text-align: justify;"> <span style="font-size:12px;">Hugues Duffau is a Professor and Chairman of Neurosurgery department at Montpellier University Medical Center and Head of the INSERM 1051 Team "Plasticity of the central nervous system, human stem cells and glial tumors" at Institute for Neurosciences of Montpellier (France). He is an expert in the awake cognitive neurosurgery of slow-growing brain tumors, as low-grade gliomas, a routine which he has developed since 20 years. His fundamental approach is centered on the concepts of the brain connectomics and neuroplasticity, breaking with the traditional localizationist view of cerebral processing. He has written four textbooks and over 335 publications in international journals ranging from neurosurgery to fundamental neurosciences, including cognitive sciences and brain plasticity for a total of more than 20,500 citations and with an h-index of 77. He is member of editorial boards of many journals and Reviewer for around 100 journals including: <em>New England Journal of Medicine</em>, <em>Lancet Oncology, Nature Medicine, Nature Reviews Neuroscience, Nature Reviews Neurology</em>, <em>Annals of Neurology, Brain, Cerebral Cortex, Trends in Cognitive </em></span></p> </p> <h5>Abstract:</h5> <p><p style="text-align: justify;"> <span style="font-size:14px;"><strong>Aim:</strong> Once considered a ‘‘no man’s land’’ especially when invaded by a diffuse low grade glioma (DLGG), the insula/paralimbic system remains today a surgical challenge. Surgery for insular/paralimbic DLGG involves consideration of its hidden location under the potentially eloquent operculae, the proximity to vascular tree and high density of functions not only in the insular cortex but also in the white fiber pathways passing under the insular lobe. Here, a personal consecutive series of 150 patients who underwent an insular/paralimbic DLGG revealed by seizures, with long-term follow-up, is detailed. Based upon functional and oncological results, advances and limitations of this challenging surgery are discussed.</span></p> <p style="text-align: justify;"> <strong style="font-size: 14px;">Methods:</strong><span style="font-size: 14px;"> The preoperative examination was normal in 88% of patients. All surgeries were performed under cortico-subcortical stimulation, in 134 patients while awake. A transopercular approach was favored, even in pure insular DLGG. Despite an immediate postoperative worsening in 59% of cases, all patients but two (98%) returned to baseline or better. On control MRI, 80% of resections were total or subtotal. 15 patients underwent a second or third surgery, with no additional deficit. 82% of patients are still alive with a mean follow-up of seven years.</span></p> <p style="text-align: justify;"> <strong style="font-size: 14px;">Conclusions:</strong><span style="font-size: 14px;"> This is the largest series ever reported with insular/paralimbic DLGG surgery. The better knowledge of the functional anatomy and the connectivity of the insula as well as the use of intraoperative direct stimulation mapping enabled to minimize the risk of permanent deficit (and even to improve the quality of life) while increasing the extent of resection; thus, the impact on the natural history. Therefore, surgical removal has to be considered systematically for insular/paralimbic DLGG. However, this surgery remains challenging, especially within the anterior perforating substance and the posterior part of the (dominant) insula. Repeated operations can be suggested when the first resection was not complete.</span></p> </p> </div> </div> </div> </section> <div class="well well-sm col-md-12 content-box-dotted"> <div class="content-box tracks" style="clear:both"> <ul class="list-group show"> <li class="list-group-item">Workshop: Regenerative Medicine : options for the treatment of degenerated spinal discs</li> </ul> <h5>Location: Sunset 2</h5> </div> <section> <div class="col-md-12" > <div class="affiliation bs-callout speaker-bio-abs"> <div class="bio-main"> <div class="bio"> <h4>Chair</h4> <h4>Walter BIni</h4> <p>Healthpoint Hospital, UAE</p> </div> </div> </div> </div> </section> <section> <div class="col-md-12"> <div class="affiliation bs-callout col-md-12"> <h4>Session Introduction</h4> <h4><a style="color:#63a7f4;" href="https://neurosurgery.insightconferences.com/speaker/2017/walter-bini-healthpoint-hospital-uae" >Walter Bini</a></h4> <p>Healthpoint Hospital, UAE</p> <h6>Title: <a style="color:#63a7f4" href="https://neurosurgery.insightconferences.com/abstract/2017/degenerative-disc-disease-up-front-considerations-regarding-treatment-with-mesenchymal-adipose-tissue-derived-stem-cells" >Degenerative disc disease: Up-front considerations regarding treatment with mesenchymal adipose tissue derived stem cells</a> </h6> <p>Time : <b>11:50-12:20</b></p> </div> </div> <div class="speaker-bio-abs"> <div class="bio-main"> <img src="https://d2cax41o7ahm5l.cloudfront.net/cs/speaker-photo/neurosurgery2017-Walter-Bini-54825-4652.jpg" alt="Speaker" title="Walter Bini" class="img-responsive thumbnail pull-left"> <div class="bio"> <h5>Biography:</h5> <p><p style="text-align: justify;"> <span style="font-size:12px;">Walter Bini has completed his Diploma at Westminster School, Simsbury Conn. USA and Post-graduate degree at Universidad de Zaragoza, Facultad de Medicina, Zaragoza-Spain. In 2014, he was the Middle East Chairman of ISLASS. He was Head of Neurosurgery at Sheikh Khalifa General Hospital, UAQ-UAE from 2014-2016. Currently, he is Consultant Neurosurgeon in Orthopedic department, spine section of Lanzo Hospital COF, Lanzo d’Intelvi in Italy and also Visiting Consultant Neurosurgeon in Orthopedic department at Healthpoint Hospital, UAE.</span></p> </p> <h5>Abstract:</h5> <p><p style="text-align: justify;"> <span style="font-size:14px;">Lumbar degenerative disc disease (DDD) poses an ongoing challenge as far as treatment options and alternatives, especially when considering younger patients. Over 80% of the adult population presents with one or more episodes of ongoing-progressive low-back pain (LBP). The primary cause is associated with degeneration of the intervertebral disc and which is triggered by a decrease of the nucleus pulposus cell population, as evidenced in histological studies. Definitely, in the presence of a black disc without profusion and neurological compromise, microsurgery or even fusion surgery should not be contemplated. Numerous percutaneous techniques have been propagated as proper way to treat this condition throughout the literature in the past years. They have been primarily focused on the treatment of the pain generated by the involved disc and the subsequent segmental insufficiency, without addressing the degeneration of the disc and this have had limited success and remain as pain management tools. Some significant trials in the past (i.e. Chondrocyte transplantation trial) and the increasing recent research and achievements with more biological strategies as far as tissue regeneration have motivated the development of a new treatment concept initially applicable to the lumbar spine which will be presented and discussed. Advancements have led to a significant improvement in the understanding of the cell environment and tissue transplantation at a molecular, cellular and immunobiological level. Adipose tissue has already become a central source of clinical and research work involving adipose tissue derived progenitor cells. Endothelial and mesenchymal stem cells derived from adipose tissue are being considered and used in an array of clinical conditions and seem to have clear therapeutic benefits for many disease conditions including those affecting bone, cartilage and muscle. The use of an accessible source with abundant cells which have a high potential for regeneration clearly is superior in comparison to the chondrocyte option for the lumbar disc. Mesenchymal cells have a high self-renewal capacity and a potential for multi lineage differentiation. For this, adipose tissue derived MSCs (ADMSCs) are optimal candidates for tissue regeneration and can be obtained from the patient in a one-step procedure-treatment. </span></p> </p> </div> </div> </div> </section> <section> <div class="col-md-12"> <div class="affiliation bs-callout col-md-12"> <h4><a style="color:#63a7f4;" href="https://neurosurgery.insightconferences.com/speaker/2017/karin-wuertz-kozak-eth-zurich-switzerland" >Karin Wuertz-Kozak</a></h4> <p>ETH Zurich, Switzerland</p> <h6>Title: <a style="color:#63a7f4" href="https://neurosurgery.insightconferences.com/abstract/2017/biology-and-regenerative-medicine-aspects-of-the-intervertebral-disc" >Biology and Regenerative Medicine Aspects of the Intervertebral Disc</a> </h6> </div> </div> <div class="speaker-bio-abs"> <div class="bio-main"> <img src="https://d2cax41o7ahm5l.cloudfront.net/cs/speaker-photo/neurosurgery2017-Karin-Wuertz-Kozak-54826-4175.jpg" alt="Speaker" title="Karin Wuertz-Kozak" class="img-responsive thumbnail pull-left"> <div class="bio"> <h5>Biography:</h5> <p><p style="text-align: justify;"> <span style="font-size:12px;">Karin Wuertz-Kozak was born in 1978 in Germany. She received her degree in Pharmaceutical Sciences from the University of Regensburg, Germany in 2003 and her Ph.D. in Human Biology from the University of Ulm, Germany in 2006, based on her work in intervertebral disc cell mechanobiology. She was a Researcher at the University of Vermont, USA from 2006 to 2007 before joining and shortly thereafter taking over the Spine Research Unit at the University of Zurich, Switzerland. After having had a dual affiliation between xxx and xxx, she was promoted to a full-time research position at the ETH Zurich, Switzerland, one of the leading universities worldwide. In the subsequent years, she complemented her educational profile with an ETH habilitation as well as an MBA degree. Since July 2016, she is Assistant Professor for Immunoengineering & Regenerative Medicine at the ETH Zurich, with a focus on the pathophysiology and treatment of degenerative disc disease.</span></p> </p> <h5>Abstract:</h5> <p><p style="text-align: justify;"> <span style="font-size:14px;">As a major weight bearing structure with limited nutritional support, the intervertebral disc is prone to degenerative changes early in life and contributes to the development of low back pain. Disc degeneration and low back pain are amongst the most relevant musculoskeletal disorders, resulting in high direct and indirect costs for our health care systems. As current treatment options are not satisfactory, the field of intervertebral disc regeneration has gained increasing importance amongst researchers as well as in the view of the World Health Organization.</span></p> <p style="text-align: justify;"> <span style="font-size:14px;">This workshop will first provide a brief introduction to the biological processes occurring during intervertebral disc degeneration and will explain the molecular mechanisms that are hypothesized to contribute to pain development. Thereafter, various approaches to counteract degeneration and pain development will be explained. For each of the discussed novel treatments, the current state of the art as well as pitfalls that may hinder, limit and at least delay translation into clinical practice will be highlighted. Novel regenerative treatment examples to be demonstrated will include (1) tissue engineering of intervertebral disc (using a variety of modern techniques), (2) stem cell treatment (including an illustration on the use of fat-derived stem cells obtained directly in the OR) and (3) the use of biologics that have the potential to interfere with disc-typical pathological mechanisms.</span></p> </p> </div> </div> </div> </section> <section> <div class="col-md-12"> <div class="affiliation bs-callout col-md-12"> <h4><a style="color:#63a7f4;" href="https://neurosurgery.insightconferences.com/speaker/2017/katy-moncivais-celling-biosciences-usa" >Katy Moncivais</a></h4> <p>Celling Biosciences, USA</p> <h6>Title: <a style="color:#63a7f4" href="https://neurosurgery.insightconferences.com/abstract/2017/toward-scientifically-informed-stem-cell-therapies-in-spine-surgery" >Toward scientifically informed stem cell therapies in spine surgery</a> </h6> </div> </div> <div class="speaker-bio-abs"> <div class="bio-main"> <img src="https://d2cax41o7ahm5l.cloudfront.net/cs/speaker-photo/neurosurgery2017-Katy-Moncivais-54827-3064.png" alt="Speaker" title="Katy Moncivais" class="img-responsive thumbnail pull-left"> <div class="bio"> <h5>Biography:</h5> <p></p> <h5>Abstract:</h5> <p><p style="text-align: justify;"> <span style="font-size:14px;">Iliac crest bone graft (ICBG) is widely accepted as the gold standard for spinal fusion but is associated with donor site morbidities including hematoma, infection and prolonged chronic pain up to years after graft harvest. Bone graft substitutes and add-on biologics have been developed in an effort to combat these drawbacks of ICBG, but most have not considered the impact of their mechanical, biological and biochemical profiles on the process of osteogenesis. This presentation will highlight the signaling pathways associated with osteogenic differentiation of bone marrow derived mesenchymal stem cells and how those signaling pathways can be encouraged or inhibited by the properties of bone graft materials.</span></p> </p> </div> </div> </div> </section> <div class="content-box tracks" style="clear:both"> <ul class="list-group show"> <li class="list-group-item">Neurosurgery and Nursing | Brain Tumour | Skullbase Neurosurgery</li> </ul> <h5>Location: Sunset 2</h5> </div> <section> <div class="col-md-12" > <div class="affiliation bs-callout speaker-bio-abs"> <div class="bio-main"> <img src="https://d2cax41o7ahm5l.cloudfront.net/cs/session-photo/walter-bini-t-969.jpg" alt="Speaker" title="Walter Bini" class="img-responsive thumbnail pull-left"> <div class="bio"> <h4>Chair</h4> <h4>Walter Bini</h4> <p>Healthpoint Hospital, UAE</p> </div> </div> </div> </div> </section> <section> <div class="col-md-12"> <div class="affiliation bs-callout col-md-12"> <h4>Session Introduction</h4> <h4><a style="color:#63a7f4;" href="https://neurosurgery.insightconferences.com/speaker/2017/mohamed-gaber-abdel-tawab-fayoum-university-egypt-1247593737" >Mohamed Gaber Abdel Tawab</a></h4> <p>Fayoum University, Egypt</p> <h6>Title: <a style="color:#63a7f4" href="https://neurosurgery.insightconferences.com/abstract/2017/dural-fenestrations-versus-duraplasty-in-traumatic-acute-subdural-hematoma" >Dural fenestrations versus duraplasty in traumatic acute subdural hematoma</a> </h6> </div> </div> <div class="speaker-bio-abs"> <div class="bio-main"> <div class="bio"> <h5>Biography:</h5> <p><p style="text-align: justify;"> <span style="font-size:12px;">Mohamed Gaber Abdel Tawab is currently working as a Lecturer of Neurosurgery department at Fayoum University, Egypt. He completed his Residency of Neurosurgery at Cairo University Hospital in Egypt</span></p> </p> <h5>Abstract:</h5> <p><p style="text-align: justify;"> <span style="font-size:14px;"><strong>Objective: </strong>Retrospective study of 222 patients was done to determine the long-term outcome of microdiscectomy on relief of sciatic pain.</span></p> <p style="text-align: justify;"> <strong style="font-size: 14px;">Methods: </strong><span style="font-size: 14px;">This was a retrospective observational study of 222 patients who underwent microdiscectomy for sciatic pain during the period 2011 to 2013 at Faculty of Medicine, Cairo University. All patients were physically examined and interviewed. Recurrent procedures, multiple level discs were excluded from analysis. All procedures were done by same surgeon.</span></p> <p style="text-align: justify;"> <strong style="font-size: 14px;">Results: </strong><span style="font-size: 14px;">Microdiscectomy yielded immediate complete pain relief in 215 patients. In seven patients, it yielded partial pain relief. Follow up to three years postoperatively, 205 patients remained absolutely pain free. Pain recurred in three patients after one year and in six patients during the first three years. Pain recurred in the same leg in eight patients, in the contralateral leg in two patients, and in both legs in one patient. One case presented with foot drop preoperative showed improvement. New neurological deficits developed postoperatively in one case in the form of foot drop and improved during follow up period.</span></p> <p style="text-align: justify;"> <strong style="font-size: 14px;">Conclusions: </strong><span style="font-size: 14px;">Microdiscectomy provided immediate pain relief in about 96% of cases, and the long-term outcome of microdiscectomy has a very good satisfactory result.</span></p> </p> </div> </div> </div> </section> <section> <div class="col-md-12"> <div class="affiliation bs-callout col-md-12"> <h4><a style="color:#63a7f4;" href="https://neurosurgery.insightconferences.com/speaker/2017/ahmed-rezk-cairo-university-egypt" >Ahmed Rezk</a></h4> <p>Cairo University, Egypt</p> <h6>Title: <a style="color:#63a7f4" href="https://neurosurgery.insightconferences.com/abstract/2017/testing-the-effect-of-novel-molecules-on-glioblastoma-cells" >Testing the effect of novel molecules on glioblastoma cells</a> </h6> </div> </div> <div class="speaker-bio-abs"> <div class="bio-main"> <div class="bio"> <h5>Biography:</h5> <p></p> <h5>Abstract:</h5> <p><p style="text-align: justify;"> <strong>Introducton:</strong> Glioblastoma (GBM) is the most abundant malignant tumor in adults (McDowell et al., 2011, Bush et al., 2016) with an incidence of 3.19 cases per 100,000 person/year (Dolecek et al., 2012). GBM is the most aggressive brain neoplasm, with a high probability of recurrence. The pattern of growth of GBM is highly infiltrative which minimize chances for total resection of tumor. The traditional treatment for glioblastoma includes surgical removal followed by chemotherapy and</p> <p style="text-align: justify;"> radiotherapy depending on clinical condiUon (Stupp et al., 2005). However, the recurrence rate is high and oXen resistance to both chemotherapy and radiotherapy ensues. In addition, it may affect the deeper brain tissues, thus preventing surgical option as an initial step for treatment (Weller et al., 2013). Therefore, new therapeutic tools are needed.</p> <p style="text-align: justify;"> <strong>Aim of the study:</strong> The current study aims at assessing the effect on the human U87 glioma cell line of novel substances, synthesized by Prof. Zago<o’s laboratory, that can be used as promising therapeutic agents. The substances were chosen for showing some similarity in their structure with a component of the bee’s propolis and some plants, caffeic acid phenethyl ester (CAPE), which has been shown to have some effect in different cancer types (Chung et al. 2004).</p> <p style="text-align: justify;"> <strong>Materials & methods:</strong></p> <p style="text-align: justify;"> • Cell culture techniques according to lab protocol</p> <p style="text-align: justify;"> • Cells were treated for 24 or 72 hours with one of the 10 substances (see below)</p> <p style="text-align: justify;"> • Wright staining, count cells to determine the percentage of apoptotic and necrotic cells</p> <p style="text-align: justify;"> • Measurement of cell migration by In Vitro Scratch Assay (wound healing experiment)</p> <p style="text-align: justify;"> • Statistical analysis: t-test, each treatment vs. control (DMSO at the same concentration used for treatments).</p> <p style="text-align: justify;"> <strong>Results:</strong> Among 10 different novel substances tested, substances 5, 7, 8 and 9 showed variable effects, indicated by morphological and molecular evaluation. Effect ranges from apoptosis, necrosis and cytostatic effect on GBM cells.</p> <p style="text-align: justify;"> <strong>Conclusions & future works:</strong> In conclusion, an initial screening of 10 substances, different in their molecular properties, highlighted a promising scaffold that will be explored in future works. More information will be added from ongoing experiments on the expression of various proteins</p> </p> </div> </div> </div> </section> <section> <div class="col-md-12"> <div class="affiliation bs-callout col-md-12"> <h4><a style="color:#63a7f4;" href="https://neurosurgery.insightconferences.com/speaker/2017/arunkumar-prasad-taishan-medical-university-china-870563148" >Arunkumar Prasad</a></h4> <p>Taishan Medical University, China</p> <h6>Title: <a style="color:#63a7f4" href="https://neurosurgery.insightconferences.com/abstract/2017/cns-lymphatic-drainage-blockade-exacerbates-cerebral-vasospasm-and-cerebral-injury-following-subarachnoid-hemorrhage-and-partially-reversed-by-ginkgo-biloba-extract" >CNS lymphatic drainage blockade exacerbates cerebral vasospasm and cerebral injury following subarachnoid hemorrhage and partially reversed by Ginkgo biloba extract</a> </h6> </div> </div> <div class="speaker-bio-abs"> <div class="bio-main"> <div class="bio"> <h5>Biography:</h5> <p></p> <h5>Abstract:</h5> <p><p style="text-align: justify;"> <span style="font-size:14px;">Recent studies suggest that CNS lymphatic drainage pathway to extracranial lymph compartments may play an important role in the removal of substances in the brain and cerebrospinal fluid (CSF). After the onset of subarachnoid hemorrhage (SAH), large amount of macromolecular substances, such as cellular lysates, proteins, peptides, were accumulated in the brain tissue and CSF, which contribute to cerebral vasospasm and cerebral injury. The present experiment was carried out to investigate the possible role of cerebral lymphatic drainage pathway in the development of cerebral vasospasm and related cerebral injury and the influence </span><span style="font-size: 14px;">of Ginkgo biloba extract. Wistar rats were used in the experiment and animals were divided into </span><span style="font-size: 14px;">different groups. SAH models were replicated by double cisternal injection of autologous arterial hemolysate. In some animals the main cerebral lymphatic drainage way out being blocked (cerebral lymphatic blockade, CLB). Two different constituents, Ginkgolides and Ginkgo flavone, were given as interventions. It was found that SAH reduced the drainage of Evans blue-labeled albumin (EBA) from the brain to the olfactory bulbs, cervical lymph nodes and abdominal paraaortic lymph nodes. A kinetic analysis of 125I-labeled human serum albumin (125I-HSA), a cerebrospinal fluid (CSF) tracer, showed that the clearance rate of macromolecules in the CSF was significantly reduced after SAH. Furthermore, SAH reduced the diameters of basilar artery (BA) and increased thickness of BA. Prominent cerebral injury was found after induction of SAH. The spasm of BA and cerebral injury were partially antagonized </span><span style="font-size: 14px;">by Ginkgolides and Ginkgo flavone. It was concluded that cerebral lymphatic drainage pathway </span><span style="font-size: 14px;">exerts intrinsic protective effects against cerebral vasospasm and cerebral injury by removal of macromolecular substances in the brain and subarachnoid spaces. Ginkgolides and Ginkgo flavone may alleviate the exacerbated cerebral vasospasm and cerebral injury following SAH by CLB.</span></p> <p style="text-align: justify;"> <strong style="font-size: 14px;">Key words: </strong><span style="font-size: 14px;">subarachnoid hemorrhage; lymphatic drainage; cerebral vasospasm; cerebral injury; Ginkgolides; Ginkgo flavone</span></p> </p> </div> </div> </div> </section> <section> <div class="col-md-12"> <div class="affiliation bs-callout col-md-12"> <h4><a style="color:#63a7f4;" href="https://neurosurgery.insightconferences.com/speaker/2017/muduroglu-aynur-nisantasi-university-turkey" >Muduroglu Aynur</a></h4> <p>Nisantasi University, Turkey</p> <h6>Title: <a style="color:#63a7f4" href="https://neurosurgery.insightconferences.com/abstract/2017/is-the-safe-method-evaluate-nanotechnologic-products-in-neuronal-modulation-of-neuronal-oscillations" >Is the safe method evaluate Nanotechnologic products in Neuronal modulation of Neuronal oscillations</a> </h6> </div> </div> <div class="speaker-bio-abs"> <div class="bio-main"> <div class="bio"> <h5>Biography:</h5> <p></p> <h5>Abstract:</h5> <p><p style="text-align: justify;"> <span style="font-size:14px;">Undoubtedly, the greatest contribution of nanobiotechnology will be at neuroscience which still having a cloak of secrecy over and waiting to be discovered millions of issue to be clarified. Neuropharmacology and nanobiotechnological developments in the field of tissue engineering will provide the foundation stone in the development of neuroscience.</span></p> <p style="text-align: justify;"> <span style="font-size: 14px;">Get nutrients, dietary supplements and many drugs do not cross the blood brain barrier. The presence of this barrier, restricts medical interventions in the treatment of neurodegenerative and psychiatric diseases.</span></p> <p style="text-align: justify;"> <span style="font-size:14px;">Besides, preventing several brain diseases or intervention to psychiatric conditions, prevents showing antioxidant properties of molecules and also allows us to improve and slowing down the aging brain.</span></p> <p style="text-align: justify;"> <span style="font-size: 14px;">The aim of our study is, molecules that can pass through the barrier at high rates, to increase the success of the production of new agents in the treatment of neural diseases. The first phase of our project is completed, it is intended to activate the cholinergic system using nanotechnology. Cholinergic system, increases awareness by activating visual, audial, and almost all the senses.</span></p> <p style="text-align: justify;"> <span style="font-size: 14px;">The R&D project that we realized by support of Ministry of Science and Industry, we have developed a product that supports the functional antioxidant which is first and only developed in our country. The useful molecules in Rosmarinus officinalis and Olea Europaea are purified. Product of our study of the effect by inhibiting acetylcholinesterase was implicated microparticles using nanobiotechnologic methods. Microparticles are in no way affected by gastric acid and protecting all the bioactive molecules from gastric acid content. The impact of the product over Central Nervous System, investigated over 22 channels of 100 volunteers and evaluated with Electroencephalogram recording system plus program. The ASA program was used for analysis.</span></p> <p style="text-align: justify;"> <span style="font-size: 14px;">The results obtained up to this time, the nanoparticle products, most notably frontal-temporal region, caused the increase in almost all parts of my brain alpha and beta frequency.</span></p> <p style="text-align: justify;"> <span style="font-size: 14px;">It has been monitored that nanobiotechnological products we obtained in our study, were able to pass the blood brain barrier and the effect lasted up to 24 hours. Changes in the frequency of brain waves in the frontal and temporal regions showed that, it is effective in gathering concentration of the product and attention. The results indicate the center of nanotechnology products could be used in evaluating the bioavailability of neuronal oscillations in the central nervous system.</span></p> </p> </div> </div> </div> </section> </div> </article> </div> </div> </section> </div>  <hr /> <link href="https://d2cax41o7ahm5l.cloudfront.net/cs/css/sprite.css" rel="stylesheet" /> <link href='https://fonts.googleapis.com/css?family=Alegreya+Sans:400,700' rel='stylesheet' type='text/css'> <link href="https://www.conferenceseries.com/css/conf_custom.css" rel="stylesheet" /> <div class="col-md-12 text-center bannerObjects"> <h2>Conference Series Destinations</h2> </div> <div class="conference-category-contact-main"> <div class="clearfix conference-category"> <div class="col-md-12"> <div class="row conference-category-sub"> <div class="col-md-4 clearfix" style="padding-right:0px;"> <div class="conference-country conf_border"> <h4 class="text-center">Webinars & Conferences By <strong>Continents</strong></h4> <div class="row"> <div class="col-md-12"> <h3>Americas</h3> <div class="row"> <div class="col-md-6 col-xs-6"> <i class="conference-sprite-country sprite Canada"> </i> <a href="https://www.conferenceseries.com/canada-meetings" target="_blank" title="Click for Canada Conferences">Canada</a> </div> <div class="col-md-6 col-xs-6"> <i class="conference-sprite-country sprite Brazil"> </i> <a href="https://www.conferenceseries.com/brazil-meetings" target="_blank" title="Click for Brazil Conferences">Brazil</a> </div> </div> </div> <div class="col-md-12"> <h3> Asia-Pacific  </h3> <div class="row"> <div class="col-md-6 col-xs-6"> <i class="conference-sprite-country sprite Australia"> </i> <a href="https://www.conferenceseries.com/australia-meetings" target="_blank" title="Australia Conferences">Australia</a> </div> <div class="col-md-6 col-xs-6"> <i class="conference-sprite-country sprite China"> </i> <a href="https://www.conferenceseries.com/china-meetings" target="_blank" title="China Conferences">China</a> </div> <div class="col-md-6 col-xs-6"> <i class="conference-sprite-country sprite HongKong"> </i> <a href="https://www.conferenceseries.com/hong-kong-meetings" target="_blank" title="Hong Kong Conferences">Hong Kong</a> </div> <div class="col-md-6 col-xs-6"> <i class="conference-sprite-country sprite India"> </i> <a href="https://www.conferenceseries.com/india-meetings" target="_blank" title="India Conferences">India</a> </div> <div class="col-md-6 col-xs-6"> <i class="conference-sprite-country sprite japan"> </i> <a href="https://www.conferenceseries.com/japan-meetings" target="_blank" title="japan Conferences">japan</a> </div> <div class="col-md-6 col-xs-6"> <i class="conference-sprite-country sprite NewZealand"> </i> <a href="https://www.conferenceseries.com/newzealand-meetings" target="_blank" title="NewZealand Conferences">NewZealand</a> </div> <div class="col-md-6 col-xs-6"> <i class="conference-sprite-country sprite Philippines"> </i> <a href="https://www.conferenceseries.com/philippines-meetings" target="_blank" title="Philippines Conferences">Philippines</a> </div> <div class="col-md-6 col-xs-6"> <i class="conference-sprite-country sprite Singapore"> </i> <a href="https://www.conferenceseries.com/singapore-meetings" target="_blank" title="Singapore Conferences">Singapore</a> </div> </div> </div> <div class="col-md-12"> <h3>Europe</h3> <div class="row">  <div class="col-md-6 col-xs-6"><i class="conference-sprite-country sprite Austria"></i> <a href="https://www.conferenceseries.com/austria-meetings" target="_blank" title="Austria Conferences">Austria</a> </div> <div class="col-md-6 col-xs-6"><i class="conference-sprite-country sprite Belgium"></i> <a href="https://www.conferenceseries.com/belgium-meetings" target="_blank" title="Belgium Conferences">Belgium</a> </div> <div class="col-md-6 col-xs-6"><i class="conference-sprite-country sprite CzechRepublic"></i> <a href="https://www.conferenceseries.com/czech-republic-meetings" target="_blank" title="Czech Republic Conferences">CzechRepublic</a> </div> <div class="col-md-6 col-xs-6"><i class="conference-sprite-country sprite Denmark"></i> <a href="https://www.conferenceseries.com/denmark-meetings" target="_blank" title="Denmark Conferences">Denmark</a> </div> <div class="col-md-6 col-xs-6"><i class="conference-sprite-country sprite Finland"></i> <a href="https://www.conferenceseries.com/finland-meetings" target="_blank" title="Finland Conferences">Finland</a> </div> <div class="col-md-6 col-xs-6"><i class="conference-sprite-country sprite France"></i> <a href="https://www.conferenceseries.com/france-meetings" target="_blank" title="France Conferences">France</a> </div> <div class="col-md-6 col-xs-6"><i class="conference-sprite-country sprite Germany"></i> <a href="https://www.conferenceseries.com/germany-meetings" target="_blank" title="Germany Conferences">Germany</a> </div> <div class="col-md-6 col-xs-6"><i class="conference-sprite-country sprite Greece"></i> <a href="https://www.conferenceseries.com/greece-meetings" target="_blank" title="Greece Conferences">Greece</a> </div> <div class="col-md-6 col-xs-6"><i class="conference-sprite-country sprite Hungary"></i> <a href="https://www.conferenceseries.com/hungary-meetings" target="_blank" title="Hungary Conferences">Hungary</a> </div> <div class="col-md-6 col-xs-6"><i class="conference-sprite-country sprite Ireland"></i> <a href="https://www.conferenceseries.com/ireland-meetings" target="_blank" title="Ireland Conferences">Ireland</a> </div> <div class="col-md-6 col-xs-6"><i class="conference-sprite-country sprite Italy"></i> <a href="https://www.conferenceseries.com/italy-meetings" target="_blank" title="Italy Conferences">Italy</a> </div> <div class="col-md-6 col-xs-6"><i class="conference-sprite-country sprite Luxembourg"></i> <a href="https://www.conferenceseries.com/luxembourg-meetings" target="_blank" title="Luxembourg Conferences">Luxembourg</a> </div> <div class="col-md-6 col-xs-6"><i class="conference-sprite-country sprite Netherlands"></i> <a href="https://www.conferenceseries.com/netherlands-meetings" target="_blank" title="Netherlands Conferences">Netherlands</a> </div> <div class="col-md-6 col-xs-6"><i class="conference-sprite-country sprite Norway"></i> <a href="https://www.conferenceseries.com/norway-meetings" target="_blank" title="Norway Conferences">Norway</a> </div> <div class="col-md-6 col-xs-6"><i class="conference-sprite-country sprite Poland"></i> <a href="https://www.conferenceseries.com/poland-meetings" target="_blank" title="Poland Conferences">Poland</a> </div> <div class="col-md-6 col-xs-6"><i class="conference-sprite-country sprite Portugal"></i> <a href="https://www.conferenceseries.com/portugal-meetings" target="_blank" title="Portugal Conferences">Portugal</a> </div> <div class="col-md-6 col-xs-6"><i class="conference-sprite-country sprite Romania"></i> <a href="https://www.conferenceseries.com/romania-meetings" target="_blank" title="Romania Conferences">Romania</a> </div> <div class="col-md-6 col-xs-6"><i class="conference-sprite-country sprite Russia"></i> <a href="https://www.conferenceseries.com/russia-meetings" target="_blank" title="Russia Conferences">Russia</a> </div> <div class="col-md-6 col-xs-6"><i class="conference-sprite-country sprite Slovenia"></i> <a href="https://www.conferenceseries.com/slovenia-meetings" target="_blank" title="Slovenia Conferences">Slovenia</a> </div> <div class="col-md-6 col-xs-6"><i class="conference-sprite-country sprite SouthAfrica"></i> <a href="https://www.conferenceseries.com/south-africa-meetings" target="_blank" title="South Africa Conferences">SouthAfrica</a> </div> <div class="col-md-6 col-xs-6"><i class="conference-sprite-country sprite Spain"></i> <a href="https://www.conferenceseries.com/spain-meetings" target="_blank" title="Spain Conferences">Spain</a> </div> <div class="col-md-6 col-xs-6"><i class="conference-sprite-country sprite Sweden"></i> <a href="https://www.conferenceseries.com/sweden-meetings" target="_blank" title="Sweden Conferences">Sweden</a> </div> <div class="col-md-6 col-xs-6"><i class="conference-sprite-country sprite Switzerland"></i> <a href="https://www.conferenceseries.com/switzerland-meetings" target="_blank" title="Switzerland Conferences">Switzerland</a> </div> <div class="col-md-6 col-xs-6"><i class="conference-sprite-country sprite UK"></i> <a href="https://www.conferenceseries.com/uk-meetings" target="_blank" title="UK Conferences">UK</a> </div> </div> </div> </div>  </div> </div> <div class="col-md-4 clearfix" style="padding-left:20px;"> <div class="conference-place conf_border"> <h4 class="text-center"><strong>Medical & Clinical</strong> Webinars & Conferences</h4> <div class="row"> <div class="col-md-12 col-sm-12 col-xs-6"><ul class="list-unstyled webniar_conf_list"><li><a href="https://www.conferenceseries.com/diabetes-endocrinology-meetings" target="_blank" title="Click for more information"><i class="fa fa-angle-right"></i>Diabetes & Endocrinology</a></li><li><a href="https://www.conferenceseries.com/healthcare-management-meetings" target="_blank" title="Click for more information"><i class="fa fa-angle-right"></i>Healthcare Management</a></li><li><a href="https://www.conferenceseries.com/medical-ethics-health-policies-meetings" target="_blank" title="Click for more information"><i class="fa fa-angle-right"></i>Medical Ethics & Health Policies</a></li><li><a href="https://www.conferenceseries.com/ophthalmology-meetings" target="_blank" title="Click for more information"><i class="fa fa-angle-right"></i>Ophthalmology</a></li><li><a href="https://www.conferenceseries.com/physical-therapy-rehabilitation-meetings" target="_blank" title="Click for more information"><i class="fa fa-angle-right"></i>Physical Therapy Rehabilitation</a></li><li><a href="https://www.conferenceseries.com/reproductive-medicine-women-healthcare-meetings" target="_blank" title="Click for more information"><i class="fa fa-angle-right"></i>Reproductive Medicine & Women Healthcare</a></li></ul></div><div class="col-md-12 col-sm-12 col-xs-6"><ul class="list-unstyled webniar_conf_list"><li><a href="https://www.conferenceseries.com/gastroenterology-meetings" target="_blank" title="Click for more information"><i class="fa fa-angle-right"></i>Gastroenterology</a></li><li><a href="https://www.conferenceseries.com/infectious-diseases-meetings" target="_blank" title="Click for more information"><i class="fa fa-angle-right"></i>Infectious Diseases</a></li><li><a href="https://www.conferenceseries.com/obesity-meetings" target="_blank" title="Click for more information"><i class="fa fa-angle-right"></i>Obesity</a></li><li><a href="https://www.conferenceseries.com/palliativecare-meetings" target="_blank" title="Click for more information"><i class="fa fa-angle-right"></i>Palliativecare</a></li><li><a href="https://www.conferenceseries.com/radiology-meetings" target="_blank" title="Click for more information"><i class="fa fa-angle-right"></i>Radiology</a></li></ul></div> <br> </div> </div> </div> <div class="col-md-4 conference-subjects"> <div class="conference-place conf_border"> <h4 class="text-center">Webinars & Conferences By <strong>Subject</strong></h4> <div class="row"> <div class="col-md-6 col-sm-6 col-xs-6"><ul class="list-unstyled"><li><a href="https://www.conferenceseries.com/agri-food-aqua-meetings" target="_blank" title="Click for more information"><i class="fa fa-angle-right"></i>Agri, Food & Aqua</a></li><li><a href="https://www.conferenceseries.com/veterinary-meetings" target="_blank" title="Click for more information"><i class="fa fa-angle-right"></i>Animal Science and Veterinary</a></li><li><a href="https://www.conferenceseries.com/biotechnology-meetings" target="_blank" title="Click for more information"><i class="fa fa-angle-right"></i>Biotechnology</a></li><li><a href="https://www.conferenceseries.com/cardiology-meetings" target="_blank" title="Click for more information"><i class="fa fa-angle-right"></i>Cardiology</a></li><li><a href="https://www.conferenceseries.com/chemistry-meetings" target="_blank" title="Click for more information"><i class="fa fa-angle-right"></i>Chemistry</a></li><li><a href="https://www.conferenceseries.com/dermatology-meetings" target="_blank" title="Click for more information"><i class="fa fa-angle-right"></i>Dermatology</a></li><li><a href="https://www.conferenceseries.com/environmental-sciences-meetings" target="_blank" title="Click for more information"><i class="fa fa-angle-right"></i>Environmental Sciences</a></li><li><a href="https://www.conferenceseries.com/geology-earth-science-meetings" target="_blank" title="Click for more information"><i class="fa fa-angle-right"></i>Geology & Earth science</a></li><li><a href="https://www.conferenceseries.com/immunology-meetings" target="_blank" title="Click for more information"><i class="fa fa-angle-right"></i>Immunology</a></li><li><a href="https://www.conferenceseries.com/medical-meetings" target="_blank" title="Click for more information"><i class="fa fa-angle-right"></i>Medical</a></li><li><a href="https://www.conferenceseries.com/nanotechnology-meetings" target="_blank" title="Click for more information"><i class="fa fa-angle-right"></i>Nanotechnology</a></li><li><a href="https://www.conferenceseries.com/neuroscience-meetings" target="_blank" title="Click for more information"><i class="fa fa-angle-right"></i>Neuroscience</a></li><li><a href="https://www.conferenceseries.com/nutrition-meetings" target="_blank" title="Click for more information"><i class="fa fa-angle-right"></i>Nutrition</a></li><li><a href="https://www.conferenceseries.com/orthopedics-meetings" target="_blank" title="Click for more information"><i class="fa fa-angle-right"></i>Orthopedics</a></li><li><a href="https://www.conferenceseries.com/pediatrics-meetings" target="_blank" title="Click for more information"><i class="fa fa-angle-right"></i>Pediatrics</a></li><li><a href="https://www.conferenceseries.com/pharma-meetings" target="_blank" title="Click for more information"><i class="fa fa-angle-right"></i>Pharma</a></li><li><a href="https://www.conferenceseries.com/pharmaceutical-sciences-meetings" target="_blank" title="Click for more information"><i class="fa fa-angle-right"></i>Pharmaceutical Sciences</a></li><li><a href="https://www.conferenceseries.com/psychiatry-meetings" target="_blank" title="Click for more information"><i class="fa fa-angle-right"></i>Psychiatry</a></li><li><a href="https://www.conferenceseries.com/surgery-meetings" target="_blank" title="Click for more information"><i class="fa fa-angle-right"></i>Surgery</a></li><li><a href="https://www.conferenceseries.com/vaccines-meetings" target="_blank" title="Click for more information"><i class="fa fa-angle-right"></i>Vaccines</a></li></ul></div><div class="col-md-6 col-sm-6 col-xs-6"><ul class="list-unstyled"><li><a href="https://www.conferenceseries.com/alternative-healthcare-meetings" target="_blank" title="aClick for more information"><i class="fa fa-angle-right"></i>Alternative Healthcare</a></li><li><a href="https://www.conferenceseries.com/biochemistry-meetings" target="_blank" title="aClick for more information"><i class="fa fa-angle-right"></i>Biochemistry</a></li><li><a href="https://www.conferenceseries.com/business-management-meetings" target="_blank" title="aClick for more information"><i class="fa fa-angle-right"></i>Business & Management</a></li><li><a href="https://www.conferenceseries.com/dentistry-meetings" target="_blank" title="aClick for more information"><i class="fa fa-angle-right"></i>Dentistry</a></li><li><a href="https://www.conferenceseries.com/eee-engineering-meetings" target="_blank" title="aClick for more information"><i class="fa fa-angle-right"></i>EEE & Engineering</a></li><li><a href="https://www.conferenceseries.com/genetics-molecular-biology-meetings" target="_blank" title="aClick for more information"><i class="fa fa-angle-right"></i>Genetics & Molecular Biology</a></li><li><a href="https://www.conferenceseries.com/hematology-meetings" target="_blank" title="aClick for more information"><i class="fa fa-angle-right"></i>Hematology</a></li><li><a href="https://www.conferenceseries.com/materials-science-meetings" target="_blank" title="aClick for more information"><i class="fa fa-angle-right"></i>Materials Science</a></li><li><a href="https://www.conferenceseries.com/microbiology-meetings" target="_blank" title="aClick for more information"><i class="fa fa-angle-right"></i>Microbiology</a></li><li><a href="https://www.conferenceseries.com/nephrology-meetings" target="_blank" title="aClick for more information"><i class="fa fa-angle-right"></i>Nephrology</a></li><li><a href="https://www.conferenceseries.com/nursing-meetings" target="_blank" title="aClick for more information"><i class="fa fa-angle-right"></i>Nursing</a></li><li><a href="https://www.conferenceseries.com/oncology-cancer-meetings" target="_blank" title="aClick for more information"><i class="fa fa-angle-right"></i>Oncology & Cancer</a></li><li><a href="https://www.conferenceseries.com/pathology-meetings" target="_blank" title="aClick for more information"><i class="fa fa-angle-right"></i>Pathology</a></li><li><a href="https://www.conferenceseries.com/pharma-marketing-industry-meetings" target="_blank" title="aClick for more information"><i class="fa fa-angle-right"></i>Pharma Marketing & Industry</a></li><li><a href="https://www.conferenceseries.com/physics-meetings" target="_blank" title="aClick for more information"><i class="fa fa-angle-right"></i>Physics</a></li><li><a href="https://www.conferenceseries.com/pulmonology-meetings" target="_blank" title="aClick for more information"><i class="fa fa-angle-right"></i>Pulmonology</a></li><li><a href="https://www.conferenceseries.com/toxicology-meetings" target="_blank" title="aClick for more information"><i class="fa fa-angle-right"></i>Toxicology</a></li></ul></div> </div> </div> </div> </div> </div> </div> </div> <footer class="kesava"> <div class="row conference-category-contact-main"> <div class="row clearfix conference-contact-past-reports"> <div class="col-md-12"> <div class="col-md-4 contact"> <h4>Mail us at</h4> <dl> <dt>Drop us an email for Program enquiry.</dt> <dd><a href="mailto:events@conferenceseries.com" title="Click to mail us">events@conferenceseries.com</a></dd> <dt>Sponsors / Exhibiting / Advertising.</dt> <dd><a href="mailto:neurosurgery@neuroconferences.org" title="Click to mail us">neurosurgery@neuroconferences.org</a></dd> <dt>General Queries.</dt> <dd><a href="mailto:neurosurgery2017@protonmail.com" title="Click to mail us">neurosurgery2017@protonmail.com</a></dd> </dl> </div> <div class="col-md-4 support"> <h4>Be a member and support us</h4> <ul> <li><a href="join_our_mailing_list.php" target="_blank" title="Click for more information">Join Our Mailing List</a></li> <li><a href="suggest_speaker.php" target="_blank" title="Click for more information">Suggest A Speaker</a></li> <li><a href="suggestions.php" target="_blank" title="Click for more information">Suggestions</a></li> <li><a href="invite_proposals.php" target="_blank" title="Click for more information">Invite Proposals</a></li> </ul> </div> <div class="col-md-4 past-reports"> <h4>Highlights from last year’s Convention!</h4> <ul> <li><a href="http://www.conferenceseries.com/Past_Reports/neurologists-2016-past" title="Click for more information" target="_blank">View Past Conference Report</a></li> <li><a href="http://www.conferenceseries.com/Past_Reports/neurologists-2016-gallery" title="Click for more information" target="_blank">View Conference gallery</a></li> <li><a href="http://www.omicsonline.org/ArchiveJNN/neuro-radiology-2016-proceedings.php" title="Click for more information" target="_blank">View Proceedings</a></li> </ul> </div> </div> </div> <div class="tiny-content"> <h6>Authorization Policy</h6> <p>By registering for the conference you grant permission to Conferenceseries to photograph, film or record and use your name, likeness, image, voice and comments and to publish, reproduce, exhibit, distribute, broadcast, edit and/or digitize the resulting images and materials in publications, advertising materials, or in any other form worldwide without compensation. Taking of photographs and/or videotaping during any session is prohibited. Contact us for any queries.</p> </div> </div> <div class="row footer-bottom"> <div class="col-md-6"> <ul class="social-icons icon-rotate icon-circle list-inline"> <li> <a href=""><i class="fa fa-rss"></i></a></li> <li> <a href=""><i class="fa fa-facebook"></i></a></li> <li> <a href="https://twitter.com/Neuro_Surgery17"><i class="fa fa-twitter"></i></a></li> <li> <a href=""><i class="fa fa-linkedin"></i></a></li> <li> <a href=""><i class="fa fa-youtube"></i></a></li> <li> <a href=""><i class="fa fa-google-plus"></i></a></li> <li> <a href=""><i class="fa blog">B</i></a></li> <li> <a href=""><i class="fa fa-pinterest"></i></a></li> <li> <a href=""><i class="fa fa-flickr"></i></a></li> </ul> </div> <div class="col-md-6"> <p class="copy-right">Copyright 漏 2023 <a href="http://conferenceseries.com/" title="Click for more Information" target="_blank">ConferenceSeries llc LTD</a>, All Rights Reserved.</p> </div> </div> </footer> </div>  <script src="https://ajax.googleapis.com/ajax/libs/jquery/1.11.2/jquery.min.js"></script>  <script type="text/javascript"> window.jQuery || document.write('<script src="https://d2cax41o7ahm5l.cloudfront.net/cs/js/jquery-1.11.2.min.js"><\/script>') </script>  <script src="https://maxcdn.bootstrapcdn.com/bootstrap/3.3.4/js/bootstrap.min.js"></script>  <script type="text/javascript"> if (typeof ($.fn.modal) === 'undefined') { document.write('<script src="https://d2cax41o7ahm5l.cloudfront.net/cs/js/bootstrap.min.js"><\/script>') } </script>  <script type="text/javascript"> $(document).ready(function () { var bodyColor = $('body').css('color'); if (bodyColor != '#333') { $("head").prepend('<link rel="stylesheet" href="https://d2cax41o7ahm5l.cloudfront.net/cs/css/bootstrap.min.css">'); } }); </script> <script type="text/javascript" src="https://d2cax41o7ahm5l.cloudfront.net/cs/js/bootstrap-submenu.min.js"></script> <script type="text/javascript" src="https://d2cax41o7ahm5l.cloudfront.net/cs/js/script.js"></script> <script type="text/javascript" src="https://d2cax41o7ahm5l.cloudfront.net/cs/js/bootstrap-submenu.min.js"></script> <script type="text/javascript"> (function () { var ga = document.createElement('script'); ga.type = 'text/javascript'; ga.async = true; ga.src = ('https:' == document.location.protocol ? 'https://ssl' : 'http://www') + '.google-analytics.com/ga.js'; var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(ga, s); })(); </script> <div id="fb-root"></div>  <div id="fb-customer-chat" class="fb-customerchat"> </div> <script> var chatbox = document.getElementById('fb-customer-chat'); chatbox.setAttribute("page_id", "191831474319202"); chatbox.setAttribute("attribution", "biz_inbox"); </script>  <script> window.fbAsyncInit = function() { FB.init({ xfbml : true, version : 'v15.0' }); }; (function(d, s, id) { var js, fjs = d.getElementsByTagName(s)[0]; if (d.getElementById(id)) return; js = d.createElement(s); js.id = id; js.src = 'https://connect.facebook.net/en_US/sdk/xfbml.customerchat.js'; fjs.parentNode.insertBefore(js, fjs); }(document, 'script', 'facebook-jssdk')); </script> </body> </html> <style type="text/css"> .affiliation { text-align: left; } .top-search { position: initial; right: 0; bottom: 10px; } </style>

CINXE.COM

Scientific Program | Techical Program | Neurosurgery Conference | Neurology Conference | Neurologists Conference | Spinal Sugery Conference | Paris | Europe | USA | Middle East | 2017